Artemisinins in autoimmune diseases: effects and mechanisms in systemic lupus erythematosus and rheumatoid arthritis
British Journal of Pharmacology · 2025
DOI: 10.1111/bph.70086 ↗At a glance
Übersichtsarbeit in British Journal of Pharmacology, 2025. Written by Fanchao Zhou and 4 co-authors. Institution: Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China. Major MEDLINE topics: Artemisinins, Lupus Erythematosus, Systemic, Arthritis, Rheumatoid, Autoimmune Diseases. Cited 11 times so far (Crossref); 166 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Natural Science Foundation of China.
Abstract (original language)
Autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) result from immune self‐tolerance loss, causing tissue damage. Standard treatments targeting late‐stage inflammation often have serious side effects. Artemisinin, known for its antimalarial properties, shows potential immunomodulatory effects. This review examines artemisinin's application in SLE and RA, emphasizing its therapeutic potential and mechanism insights. From 2014 to 2024, we searched PubMed, Web of Science, and Google Scholar using keywords ‘artemisinins’, ‘SLE’, and ‘RA’. Artemisinins modulate immune pathways (PI3K/Akt, HIF‐1α/NF‐κB, Nrf2/HO‐1, p62/Nrf2), balance Th17/Treg cells and M1/M2 macrophages, inhibit ROS production, and suppress B‐cells, fibroblast‐like synoviocytes, and osteoclasts, affecting SLE/RA progression. Structure–activity relationship analysis indicates that the effects of artemisinin are mainly due to their endoperoxide bridge and sesquiterpene lactone structures. This review highlights artemisinin's potential for treating various autoimmune diseases and aiding drug development.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
- Nanchang Health Vocational And Technical College, Nanchang, China.
Funding
- National Natural Science Foundation of China
Cite
APA
Zhou, F., Li, G., Tan, R., Wu, G., & Deng, C. (2025). Artemisinins in autoimmune diseases: effects and mechanisms in systemic lupus erythematosus and rheumatoid arthritis. British Journal of Pharmacology. https://doi.org/10.1111/bph.70086
Vancouver
Zhou F, Li G, Tan R, Wu G, Deng C. Artemisinins in autoimmune diseases: effects and mechanisms in systemic lupus erythematosus and rheumatoid arthritis. British Journal of Pharmacology. 2025. doi:10.1111/bph.70086
BibTeX
@article{Zhou2025,
author = {Zhou, Fanchao and Li, Guoming and Tan, Ruixiang and Wu, Guodong and Deng, Changsheng},
title = {Artemisinins in autoimmune diseases: effects and mechanisms in systemic lupus erythematosus and rheumatoid arthritis},
journal = {British Journal of Pharmacology},
year = {2025},
doi = {10.1111/bph.70086}
}
EUVIMED